Engkang, Humaydi A.
HRN: 22-34-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
METRONIDAZOLE 500MG (TAB)
12/25/2022
01/01/2023
PO
500mg
TID
Fistula In Ano
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes